Lazard Asset Management LLC Adicet Bio, Inc. Transaction History
Lazard Asset Management LLC
- $61.8 Billion
- Q4 2024
A detailed history of Lazard Asset Management LLC transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Lazard Asset Management LLC holds 414 shares of ACET stock, worth $409. This represents 0.0% of its overall portfolio holdings.
Number of Shares
414
Previous 414
-0.0%
Holding current value
$409
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding ACET
# of Institutions
72Shares Held
59.7MCall Options Held
4.2KPut Options Held
17.3K-
Orbimed Advisors LLC San Diego, CA11.4MShares$11.3 Million0.3% of portfolio
-
Tang Capital Management LLC San Diego, CA8.15MShares$8.06 Million0.59% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$7.47 Million0.12% of portfolio
-
Goldman Sachs Group Inc New York, NY3.75MShares$3.72 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$3.17 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $39.6M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...